Current Report Filing (8-k)
January 19 2021 - 4:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
January 12, 2021
BIOHITECH GLOBAL, INC.
(Exact Name of Registrant as
Specified in its Charter)
Delaware
|
001-36843
|
46-2336496
|
(State of Organization)
|
(Commission File Number)
|
(I.R.S. Employer
|
|
|
Identification No.)
|
80 Red Schoolhouse Road, Suite 101,
Chestnut Ridge, NY 10977
(Address of principal executive offices)
Registrant’s telephone number, including
area code: 845-262-1081
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
¨
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
¨
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value per share
|
BHTG
|
NASDAQ Capital Market
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02.
|
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
|
Effective January 12,
2021, Douglas VanOort resigned as a member of the Board of Directors of BioHiTech Global, Inc. (the “Registrant”) and
as a Member of the Registrant’s Audit Committee. Mr. VanOort did not indicate that his decision to resign was a result of
any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Mr. Rohleder was appointed to replace Mr.
VanOort’s vacancy on the Registrant’s Audit Committee.
SIGNATURES
Pursuant to the requirements
of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: January 19, 2021
|
BIOHITECH GLOBAL, INC.
|
|
|
|
|
|
By:
|
/s/ Brian C. Essman
|
|
|
Name:
|
Brian C. Essman
|
|
|
Title:
|
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
|
BioHiTech Global (NASDAQ:BHTG)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioHiTech Global (NASDAQ:BHTG)
Historical Stock Chart
From Apr 2023 to Apr 2024